• August 4, 2020

    Tchaikapharma High Quality Medicines retains its position as the most expensive Bulgarian company on the BSE. After the players on the stock exchange estimated the pharmaceutical company at BGN 1,027,500,000 at the end of June, at the beginning of August Tchaikapharma added more value to its market capitalization reaching BGN 1,056,250,000.   Read the full […]

  • July 13, 2020

    There is a company on the Bulgarian Stock Exchange with a value of over a billion leva, according to data in the bulletin of the stock exchange operator for the second quarter. This is Tchaikapharma High Quality Medicines. By the end of June, the stock exchange players estimated the pharmaceutical company at BGN 1,027,500,000.   […]

  • March 23, 2020

    Tchaikapharma High Quality Medicines’ shares increased by 1.8% at the end of the trading Monday, March 23, and the closing price reached BGN 11.60. Since the beginning of the year, the company has increased its share price by 6.42%.

  • January 7, 2020

    In the past year, Tchaikapharma has consolidated its leading position through the successful development of numerous scientific projects, the basis of which is advanced research work on the development and implementation of innovative combined medicinal products (polypills) that have not been applied so far in the world medical practice. A number of successful laboratory studies […]

  • September 3, 2018

    Distant leader in the treatment of cardiovascular disease among all drug manufacturers present on the Bulgarian market with market share 10.57% in 2017 and 11.39% for the first half of 2018 (Source:  IQVIA/IMS Health), with deep potential for further growth following the market entry of newly developed and introduced medicaments. Tchaikapharma 7TH

  • August 25, 2017

    The Financial Supervision Commission (FSC) registered the shares issued by Tchaikapharma High Quality Medicines Inc. as a result of an increase of the company’s capital with a view to trading on a regulated securities market. This is evident from the regulator’s decisions at the meeting held on the 23rd of August. The equity issue amounts […]

  • July 14, 2017

    The current capital of the pharmaceutical company is BGN 64.3 million. Tchaikapharma High Quality Medicines Inc. announced that following the entry in the Commercial Register the capital of the company was increased by BGN 7.7 million, the announcement came through the BSE-Sofia. The current capital of the pharmaceutical company is BGN 64.3 million, divided into […]

  • June 9, 2017

    The voted dividend for 2016  is 7 700 000. The amount of the capital after the increase is BGN 64 300 000. On June 8, 2017, the Annual General Meeting of Shareholders (GMS) of Tchaikapharma High Quality Medicines Inc. was held with the required quorum. A total of 56,562,089 shares were represented – all with […]

  • April 4, 2017

    On the basis of art.27, par.1. it. 2 of the Ordinance No. 2 of the Financial Supervision Commission (FSC), we notify the following circumstances relating to Tchaikapharma High Quality Medicines Inc., which constitute “internal information” within the meaning of Art. 4 of the Law Against Market Abuse with Financial Instruments and Ordinance No. 2 of […]

  • December 7, 2016

    The outgoing 2016 was a wonderful year of continued progress for Tchaikapharma. It was the first full year since Tchaikapharma was listed as a public company on the Bulgarian Stock Exchange (BSE) in Sofia and after share trading started on 21 May 2015. Actually and based on 3Q16 results followed by very good October and […]

  • September 9, 2016

    The decline in the price of shares of Sopharma during the trading session of Wednesday from 3.24% yesterday and the minimum recovery of only 0.24% led to a new leader among the largest public companies in Bulgaria. Another pharmaceutical company – Tchaikapharma High Quality Medicines Inc. took the forefront place with a market value of […]

  • August 8, 2016

    A total of 8 among the 40 companies included in calculating one of the main indicators of the Bulgarian Stock Exchange – BGBX40, rose more than 10%, and nine companies lose between 13 and 58% of its market valuation, according to a check made by Profit.bg. Here are the details for the best and worst […]

  • June 24, 2016

    By decision of the General Meeting, the company’s capital will be increased by BGN 7 million, which will increase in proportion the number of shares that each shareholder has. On 23rd June 2016, in the presence of the required quorum, was held the Annual General Meeting (AGM) of shareholders of Tchaikapharma High Quality Medicines AD. […]

  • June 22, 2016

    For the past year the company has reported improved results in its financial performance, introducing new products and entering new markets, as well as advancing in the field of its research and development activities   The Public company Tchaikapharma High Quality Medicines Inc. will hold its Annual General Meeting of Shareholders on 23rd of June […]

  • April 27, 2016

    Tchaikapharma High Quality Medicines Inc. invites all of the shareholders of the Company to the Annual General Meeting which will be held on 23 June 2016. You can find the full invitation wording here.

  • April 8, 2016

    At the end of the trading day (Thursday 7 April) Tchaikapharma’s shares rose most significantly – they increased by 1.21% and the closing price reached BGN 5.85. This represents another appreciation of the emission, which has risen by 6.06% since the beginning of the year.

  • March 23, 2016

    Tchaikapharma High Quality Medicines Inc. successfully launched the trading week. On Monday, the company ranked third in traded volume, having trading volume of nearly BGN 33.4 thousand. The transactions were seven, leading to a rise in the share price by 0.7% up to BGN 5.76. On Tuesday, amid the prevailing unprofitable companies on the Stock […]

  • October 30, 2015

    The results of the third quarter of 2015 confirmed the optimistic forecasts for the financial results of Tchaikapharma High Quality Medicines Inc. Obviously the long-term strategy for innovative, high-tech development of the company, including expansion into new markets and focus on the needs of patients warrants further optimism According to the data of IMS, a […]

  • May 26, 2015

    With the decision of 25.05.2015, the Financial Supervision Commission confirmed the supplement to the prospectus for capital increase and the admission to trading of another 6.1 million shares of Tchaikapharma High Quality Medicines Inc. Based on the decision of the General Meeting of Shareholders as of 28.04.2015, the capital of the company was increased by […]

  • May 22, 2015

    Today is the second trading day of the shares of Tchaikapharma High Quality Medicines AD. The Bulgarian Stock Exchange transactions were concluded at higher levels compared to yesterday – BGN 4.27, BGN 4.30 and BGN 4.31 per share – an increase of 1.17%. The market closed at demand of BGN 4.31 and supply of BGN […]

  • May 21, 2015

    The stock trade with the shares of Tchaikapharma High Quality Medicines AD has started at the Bulgarian Stock Exchange at the price of BGN 4.26 per share. The market closed with a demand for BGN 4.27 and a supply of BGN 4.28 per share.

  • May 14, 2015

    At a meeting of the Board of Directors of the Bulgarian Stock Exchange – Sofia AD, the following decision was taken in Protocol 19 / 13.05.2015: In connection with the submitted application pursuant to Art. 17, Para. 1 of Part III, Rules for Admission to Trading, the Board of Directors of the BSE-Sofia, pursuant to […]

  • May 13, 2015

    Tchaikapharma High Quality Medicines AD has declared the admission to trading of its shares on the Bulgarian Stock Exchange, was confirmed by the operator. The ISIN code of the issue is BG1100008074. The share issue amounts to BGN 43.5 million, divided into the same number of shares with a nominal value of BGN 1. Its […]